Microbot Medical (MBOT) Profit After Tax (2010 - 2026)

Microbot Medical (MBOT) has 17 years of Profit After Tax data on file, last reported at -$3.7 million in Q1 2026.

• Quarterly Profit After Tax fell 41.14% year-over-year to -$3.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$14.2 million (down 21.75% YoY) and the FY2025 annual result came in at -$13.1 million, down 14.85% from the prior year.
• Profit After Tax fell to -$3.7 million in Q1 2026, from -$3.5 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of -$2.3 million in Q2 2023 to a low of -$3.7 million in Q1 2026.
• A 5-year average of -$3.1 million and a median of -$3.2 million in 2022 frame the typical range for Profit After Tax.
• Annual changes were most pronounced in 2023 — Profit After Tax surged 34.9% — and 2025, when it sank 41.99%.
• Tracing MBOT's Profit After Tax over 5 years: stood at -$3.0 million in 2022, then slipped by 5.2% to -$3.2 million in 2023, then slipped by 7.55% to -$3.4 million in 2024, then declined by 2.12% to -$3.5 million in 2025, then fell by 5.98% to -$3.7 million in 2026.
• The last three Profit After Tax figures came in at -$3.7 million (Q1 2026), -$3.5 million (Q4 2025), and -$3.6 million (Q3 2025), per Business Quant data.